MedPath

The GÖTEBORG prostate cancer screening 2 trial

Not Applicable
Active, not recruiting
Conditions
Prostate cancer
Cancer
Malignant neoplasm of prostate
Registration Number
ISRCTN94604465
Lead Sponsor
niversity of Gothenburg
Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36477032/ primary and secondary outcome results (added 12/12/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Male
Target Recruitment
17980
Inclusion Criteria

1. Male
2. Age 50-60
3. Living in selected municipalities in Västra Götaland, Sweden

Exclusion Criteria

Men with prior diagnosis of prostate cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath